Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

September 02, 2015 12:31 AM ET


Company Overview of Samsung Biologics Co., Ltd.

Company Overview

Samsung Biologics Co., Ltd. develops biological products through genetic engineering, cell culture technology, purification, and fill and finish technology. The company offers process development services, including cell line development programs, and upstream and downstream process development services, as well as develops, qualifies, and validates product-specific analytical methods. It also provides contract management services that comprise cGMP manufacturing programs for cell line development, process and analytical development, clinical phase I/II/III manufacturing, full-scale commercial manufacturing, and aseptic fill and finish operations. The company has a strategic alliance with Me...

125, Cheomdan-daero


Incheon,  406-840

South Korea

Key Executives for Samsung Biologics Co., Ltd.

Chief Executive Officer, President and Director
Vice President of Corporate Business Operation Team
Chief Information Officer and Vice President
Executive Vice President and Director
Senior Vice President
Compensation as of Fiscal Year 2015.

Samsung Biologics Co., Ltd. Key Developments

Samsung Biologics Co., Ltd. Presents at BIO International Convention 2015, Jun-18-2015 11:30 AM

Samsung Biologics Co., Ltd. Presents at BIO International Convention 2015, Jun-18-2015 11:30 AM. Venue: Pennsylvania Convention Center, Philadelphia, Pennsylvania, United States. Speakers: Jenifer L. Wheat, Vice President.

Samsung Biologics Co., Ltd. Presents at BIO International Convention, Jun-25-2014 03:15 PM

Samsung Biologics Co., Ltd. Presents at BIO International Convention, Jun-25-2014 03:15 PM. Venue: San Diego Convention Center, San Diego, California, United States.

Samsung Biologics Announces the Expansion of Existing Manufacturing Agreement with Bristol-Myers Squibb

Samsung BioLogics has announced that it has expanded its existing manufacturing agreement with Bristol-Myers Squibb. BMS's president of Global Manufacturing & Supply noted that the expanded agreement, will give the company flexibility to respond to increased demand in order to meet the global needs of patients. Details of which products will be covered by the deal or financial considerations have not yet been disclosed.

Similar Private Companies By Industry

Company Name Region
Bio Technology Chemical Co. Ltd. Asia
Metabio Asia
ATGen Co. Ltd. Asia
NEXGEN Biotechnologies, Inc. Asia
Naturo Bio Tech Co., Ltd. Asia

Recent Private Companies Transactions

Private Placement
July 3, 2015
Private Placement
February 5, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Samsung Biologics Co., Ltd., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at